Part 1Application and administration of Act
Administration
9Medicines Classification Committee
The Minister shall appoint under section 8 an advisory committee to be called the Medicines Classification Committee, whose duty it shall be to make recommendations to the Minister in respect of the classification of any medicines as prescription medicines or restricted medicines or pharmacy-only medicines under this Act.
The Committee shall also consider and report to the Minister on such other matters in relation to any of the purposes of this Act as may from time to time be referred to it by the Minister.
The Minister must appoint at least 7 members to the Committee.
The Minister must not appoint a person to the Committee unless they are satisfied that the person is suitably qualified to be a member.
The members of the Committee hold office for a term of 3 years, subject to subsection (5), but any member may be reappointed for 1 further term.
Any member of the Committee may at any time be removed from office by the Minister for disability, neglect of duty, or misconduct proved to the satisfaction of the Minister, or may at any time resign his office by writing addressed to the Minister.
The quorum for a meeting of the Committee is half of the membership of the Committee plus 1, rounded down to the nearest whole number.
-
Repealed -
Repealed -
Repealed
Compare
- 1960 No 97 s 6
- 1967 No 108 s 2
- 1979 No 28 s 5(1)
Notes
- Section 9(3): replaced, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).
- Section 9(3A): inserted, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).
- Section 9(4): replaced, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).
- Section 9(6): replaced, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).
- Section 9(7): repealed, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).
- Section 9(8): repealed, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).
- Section 9(9): repealed, on , by section 15 of the Medicines Amendment Act 2025 (2025 No 66).


